EP 4367252 A2 20240515 - PHARMACEUTICAL COMPOSITION OF NON-ENVELOPED VIRUS
Title (en)
PHARMACEUTICAL COMPOSITION OF NON-ENVELOPED VIRUS
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG EINES NICHTUMHÜLLTEN VIRUS
Title (fr)
COMPOSITION PHARMACEUTIQUE DE VIRUS NON ENVELOPPÉ
Publication
Application
Priority
- RU 2021120143 A 20210708
- RU 2022050212 W 20220704
Abstract (en)
[origin: WO2023282796A2] The present invention relates to the field of pharmaceuticals, gene therapy and medicine, specifically to pharmaceutical compositions of a vector based on recombinant non-enveloped virus, in particular the recombinant adeno-associated virus (rAAV), which compositions may be aqueous or lyophilized compositions and may be used for the treatment and prevention of various diseases.
IPC 8 full level
C12N 15/86 (2006.01); A61K 9/08 (2006.01); A61K 9/19 (2006.01); A61K 35/76 (2015.01); A61K 47/02 (2006.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61K 47/34 (2017.01); A61K 47/40 (2006.01); C12N 7/00 (2006.01)
CPC (source: EP)
A61K 9/08 (2013.01); A61K 9/19 (2013.01); A61K 35/76 (2013.01); A61K 47/40 (2013.01); C12N 15/86 (2013.01); C12N 2750/14143 (2013.01); C12N 2750/14151 (2013.01); Y02A 50/30 (2018.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2023282796 A2 20230112; WO 2023282796 A3 20230216; AR 126417 A1 20231011; CL 2024000062 A1 20240614; CN 117999353 A 20240507; CO 2024000073 A2 20240429; EC SP24001599 A 20240229; EP 4367252 A2 20240515; MX 2024000472 A 20240212
DOCDB simple family (application)
RU 2022050212 W 20220704; AR P220101800 A 20220708; CL 2024000062 A 20240108; CN 202280061040 A 20220704; CO 2024000073 A 20240105; EC DI202401599 A 20240108; EP 22838112 A 20220704; MX 2024000472 A 20220704